Detalhe da pesquisa
1.
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Am J Hematol
; 99(3): 350-359, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165016
2.
Peripheral levels of monocytic myeloid-derived suppressive cells before and after first induction predict relapse and survivals in AML patients.
J Cell Mol Med
; 26(21): 5486-5492, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226545
3.
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Clin Infect Dis
; 75(1): 88-97, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34596213
4.
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
J Antimicrob Chemother
; 77(9): 2546-2556, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748614
5.
Effectiveness of a third dose of BNT162b2 anti-SARS-CoV-2 mRNA vaccine over a 6-month follow-up period in allogenic hematopoietic stem cells recipients.
Hematol Oncol
; 40(5): 1097-1099, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468662
6.
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.
Acta Oncol
; 61(11): 1332-1338, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214787
7.
Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
J Immunol
; 205(5): 1441-1448, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747504
8.
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report.
Acta Haematol
; 145(5): 537-541, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35724631
9.
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.
Haematologica
; 106(3): 701-707, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241844
10.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Acta Oncol
; 60(4): 466-474, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33112687
11.
Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide.
J Immunol
; 202(7): 2141-2152, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787107
12.
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
Ann Hematol
; 99(8): 1855-1862, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564196
13.
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
Ann Hematol
; 99(7): 1595-1604, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417940
14.
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide.
Ann Hematol
; 99(6): 1341-1350, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342134
15.
Influence of Donor Type (Sibling versus Matched Unrelated Donor versus Haploidentical Donor) on Outcomes after Clofarabine-Based Reduced-Intensity Conditioning Allograft for Myeloid Malignancies.
Biol Blood Marrow Transplant
; 25(7): 1465-1471, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30928627
16.
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients.
Blood
; 139(1): 134-137, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818411
17.
FLT3 ligand plasma levels have no impact on outcomes after allotransplant in acute leukemia.
Cytokine
; 120: 85-87, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31035172
18.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.
Ann Hematol
; 98(6): 1441-1447, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30874851
19.
Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES Study.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133564
20.
A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients.
Br J Haematol
; 183(5): 736-746, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30406952